Daily step statistics show how activity volume varies across adult cohorts and how higher observed step counts are associated with mortality, cardiovascular, cancer, diabetes, cognitive and functional outcomes. The evidence below comes mainly from device-measured prospective cohorts, so step counts and outcomes should be read with each study’s population, dates and reference group in mind.
Key Daily Step Statistics
The most useful headline figures span activity distributions, follow-up outcomes and step intensity:
- In international cohorts measured in studies starting from 1999 to 2018, median daily steps ranged from 3,553 to 10,901 across ascending quartiles among 47,471 adults in 15 cohorts.
- In the 2003–2006 NHANES baseline accelerometer sample, U.S. adults aged 40 and older averaged 9,124 steps per day.
- In the 2005–2006 CARDIA baseline, middle-aged U.S. adults had a median of 9,146 steps per day.
- In the 15-cohort follow-up, 3,013 deaths occurred over a median 7.1 years among 47,471 adults.
- In prospective cohorts reviewed through February 14, 2025, 7,000 steps per day was associated with 47% lower all-cause mortality than 2,000 steps per day.
- In U.S. adults aged 40 and older followed through December 2015, mortality incidence was 76.7 per 1,000 person-years below 4,000 steps per day.
- In the same U.S. sample, mortality incidence was 4.8 per 1,000 person-years at 12,000 or more steps per day.
- In that sample, 8,000 rather than 4,000 steps per day was associated with an all-cause mortality hazard ratio of 0.49.
- In the TASPED cohort followed through June 2011, each additional 1,000 baseline steps per day was associated with a mortality hazard ratio of 0.94.
- In middle-aged CARDIA participants followed for a mean 10.8 years, 7,000–9,999 steps per day had a mortality hazard ratio of 0.28 versus fewer than 7,000.
- In evidence published through February 14, 2025, 7,000 versus 2,000 steps per day was associated with a cardiovascular disease incidence hazard ratio of 0.75.
- In the same review, 7,000 versus 2,000 steps per day was associated with a type 2 diabetes incidence hazard ratio of 0.86.
- In prospective cohorts reviewed through February 14, 2025, dementia risk was 38% lower at 7,000 versus 2,000 steps per day.
- In the same evidence base, depressive symptoms were associated with a hazard ratio of 0.78 at 7,000 versus 2,000 steps per day.
- In the same review, falls were associated with a hazard ratio of 0.72 at 7,000 versus 2,000 steps per day.
- In the 15-cohort analysis, mortality risk fell up to 6,000–8,000 steps per day among adults aged 60 and older.
- In the same analysis, mortality risk fell up to 8,000–10,000 steps per day among adults younger than 60.
- In U.S. adults aged 40 and older, the highest peak-30-minute cadence group had mortality incidence of 5.3 per 1,000 person-years.
Contents
- Daily step distributions in adults
- Daily step trends and all-cause mortality
- Daily steps and cardiovascular, cancer and diabetes outcomes
- Daily steps, mental, cognitive and functional health
- Daily steps by age, sex and race
- Daily steps, cadence and weekly walking patterns
Daily Step Distributions in Adults
Daily step statistics are not interchangeable averages. The international meta-analysis reported quartile medians, while NHANES and CARDIA describe particular U.S. cohorts with different ages, sampling designs and measurement periods.
| Population and period | Daily-step result | Definition or limitation |
|---|---|---|
| 47,471 adults in 15 international cohorts; studies starting 1999–2018 | 3,553; 5,801; 7,842; 10,901 steps/day | Ascending quartile medians |
| U.S. adults aged 40+; NHANES 2003–2006 baseline | 9,124 steps/day | Mean; accelerometer wear averaged 5.7 days |
| 2,110 Black and White adults aged 38–50; CARDIA 2005–2006 baseline | 9,146 steps/day | Median; interquartile range 7,307–11,162 |
Sources: Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts, Association of Daily Step Count and Step Intensity With Mortality Among US Adults, and Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study.
The quartile figures are not a national average. The NHANES result is a baseline mean from a representative accelerometer sample of adults aged 40 and older, and CARDIA is a middle-aged cohort rather than all U.S. adults.
Daily Step Trends and All-Cause Mortality
Across prospective cohorts, higher observed daily steps generally corresponded to lower subsequent all-cause mortality. These are observational associations, not randomized effects or universal prescriptions.
The 15-cohort meta-analysis recorded 3,013 deaths during a median 7.1 years of follow-up. Compared with the lowest quartile, mortality hazard ratios were 0.60 in quartile 2, 0.55 in quartile 3 and 0.47 in quartile 4, whose median was 10,901 steps per day.
In adults aged 40 and older in the NHANES-linked sample, unadjusted mortality incidence varied by daily-step category:
- Below 4,000 steps/day: 76.7 deaths per 1,000 person-years.
- 4,000–7,999 steps/day: 21.4 deaths per 1,000 person-years.
- 8,000–11,999 steps/day: 6.9 deaths per 1,000 person-years.
- 12,000 or more steps/day: 4.8 deaths per 1,000 person-years.
The adjusted comparison in that study was HR 0.49 for 8,000 versus 4,000 steps per day and HR 0.35 for 12,000 versus 4,000. The highest-step group was the smallest, and the associations do not prove that adding steps causes the full difference.
A dose-response meta-analysis of studies published through 2022 estimated HR 0.63 at 4,000 steps/day, HR 0.40 at 6,388 and HR 0.25 at 9,994.3, each compared with 1,895 steps/day. The reference and categories varied between cohorts, so these pooled estimates are not randomized targets.
In the TASPED prospective cohort in Tasmania, measured at baseline from 2000–2005 and followed through June 2011, each additional 1,000 baseline steps/day was associated with HR 0.94 for mortality. Increasing from sedentary levels to 10,000 steps/day was associated with 46% lower mortality risk over approximately 10 years, with a confidence interval of 18%–65%; 219 deaths occurred among 2,576 adults.
CARDIA recorded 72 deaths during 22,845 person-years of follow-up, equal to 3.4% of the 2,110-person cohort. During the mean 10.8-year follow-up, 7,000–9,999 steps/day had HR 0.28 and at least 10,000 had HR 0.45, both versus fewer than 7,000 steps/day; modeled risk differences were 53 and 41 events per 1,000 people, respectively.
Sources: Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts, Association of Daily Step Count and Step Intensity With Mortality Among US Adults, Dose-response association between the daily step count and all-cause mortality: A systematic review and meta-analysis, Objectively Measured Daily Steps and Subsequent Long Term All-Cause Mortality: The Tasped Prospective Cohort Study, and Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study.
Daily Steps and Cardiovascular, Cancer and Diabetes Outcomes
A systematic review and dose-response meta-analysis covering evidence published from 2014 through February 14, 2025 included 57 studies from 35 cohorts; 31 studies from 24 cohorts contributed to meta-analyses. At 7,000 versus 2,000 steps/day, the pooled associations were:
| Outcome | Association at 7,000 vs 2,000 steps/day | Evidence detail |
|---|---|---|
| Cardiovascular disease incidence | HR 0.75; 25% lower risk | Six studies |
| Cardiovascular disease mortality | HR 0.53; 47% lower risk | Three studies; low certainty and high heterogeneity |
| Cancer incidence | HR 0.94; non-significant 6% lower risk | Two studies; CI 0.87–1.01 |
| Cancer mortality | HR 0.63; 37% lower risk | Three studies |
| Type 2 diabetes incidence | HR 0.86; 14% lower risk | Four studies |
The cancer-incidence confidence interval includes no association, and the review described several outcome estimates as low-certainty observational evidence. The fitted relationships included inverse linear associations for cardiovascular mortality, cancer incidence, cancer mortality, type 2 diabetes incidence and depressive symptoms, but that form does not establish causality.
In the 2020 U.S. accelerometer study, 1,165 deaths occurred among 4,840 adults aged 40 and older during a mean 10.1-year follow-up. Of those deaths, 406 were cardiovascular and 283 were cancer deaths; these are cohort event counts, not population rates.
Source: Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis and Association of Daily Step Count and Step Intensity With Mortality Among US Adults.
Daily Steps, Mental, Cognitive and Functional Health
The same review found associations across cognition, mood and function at 7,000 versus 2,000 steps/day among adults in prospective cohorts:
- Dementia risk was lower, with HR 0.62 and a 95% confidence interval of 0.53–0.73, based on two studies.
- Depressive symptoms were associated with HR 0.78 and a 95% confidence interval of 0.73–0.83, based on three studies; symptom and diagnosis definitions may vary.
- Falls were associated with HR 0.72 and a 95% confidence interval of 0.65–0.81, based on four studies; certainty was very low.
The review identified inverse non-linear associations for dementia and falls, with inflection points around 5,000–7,000 steps/day. Those pooled curve summaries should not be treated as clinical prescriptions, particularly because the number of studies was small for several outcomes.
Source: Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis.
Daily Step Statistics by Age, Sex and Race
Age changes the step range at which the pooled mortality curve appeared to flatten. In the 15-cohort meta-analysis, mortality risk fell with steps up to 6,000–8,000 steps/day among adults aged 60 and older, compared with 8,000–10,000 among adults younger than 60.
CARDIA provides subgroup estimates but does not represent national demographics. Women comprised 57.1% of the cohort and Black participants 42.1% at the 2005–2006 baseline.
| CARDIA subgroup | Moderate/high step volume vs low-step group | 95% CI |
|---|---|---|
| Black participants | HR 0.30 | 0.14–0.63 |
| White participants | HR 0.37 | 0.17–0.81 |
| Women | HR 0.28 | 0.12–0.63 |
| Men | HR 0.42 | 0.20–0.88 |
These are adjusted subgroup associations during the mean 10.8-year follow-up, not randomized comparisons. The cohort was measured at ages 38–50, and its sex and race composition should not be read as a national population profile.
Sources: Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts and Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study.
Daily Steps, Cadence and Walking Patterns
Cadence describes how quickly steps occur during a selected period, whereas daily step count measures total volume. In U.S. adults aged 40 and older followed through December 2015, unadjusted mortality incidence declined across peak-30-minute cadence categories:
| Peak 30-minute cadence | Mortality incidence |
|---|---|
| 18.5–56.0 steps/min | 32.9 per 1,000 person-years |
| 56.1–69.2 steps/min | 12.6 per 1,000 person-years |
| 69.3–82.8 steps/min | 6.8 per 1,000 person-years |
| 82.9–149.5 steps/min | 5.3 per 1,000 person-years |
After adjustment for total daily steps, the highest versus lowest cadence category had HR 0.90 and was not statistically significant, with P=.34. In CARDIA, the lowest versus highest peak-30-minute intensity tertile had HR 0.98, while the lowest versus highest tertile for time at 100 steps/min or more had HR 1.38; neither association was significant, with confidence intervals of 0.54–1.77 and 0.73–2.61.
The international meta-analysis found peak 30-minute stepping-rate quartile 4 versus quartile 1 had HR 0.67 after accounting for daily step count. Peak 60-minute quartile 4 versus quartile 1 also had HR 0.67, with a 95% confidence interval of 0.50–0.90.
Time spent at 40 steps/min or faster was not significantly associated with mortality after adjustment for daily steps, HR 1.12 with a 95% confidence interval of 0.96–1.32. Time at 100 steps/min or faster was likewise not significant, HR 0.86 with a 95% confidence interval of 0.58–1.28.
Together, these findings suggest that total volume and selected cadence measures overlap, but the evidence does not establish a universal cadence threshold. Device wear-time rules, cadence definitions and outcome measurements differed among studies.
Sources: Association of Daily Step Count and Step Intensity With Mortality Among US Adults, Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study, and Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts.
The 10,000-step figure is a viable goal for more-active people in the 2025 review, but the evidence does not establish it as a required threshold. Across all sections, the reported results are predominantly device-measured prospective cohort associations; step counts, cadence, wear-time rules and outcome definitions differed, and residual confounding remains possible.